ASTA PHARMACEUTICALS CO LTD has a total of 18 patent applications. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), Taiwan and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are GTX INC, SCHWABE WILLMAR GMBH & CO and BIAL PORTELA & CA S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Taiwan | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 | |
#9 | New Zealand | 1 | |
#10 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Nishida Yasuhiro | 16 |
#2 | Fujita Takashi | 13 |
#3 | Kobayashi Satoshi | 11 |
#4 | Shinohara Ryoma | 11 |
#5 | Yokoyama Tomihisa | 7 |
#6 | Iwano Yuji | 6 |
#7 | Sakata Ryo | 6 |
#8 | Kobayashi Kaoru | 6 |
#9 | Takashina Michinori | 6 |
#10 | Maeda Sachi | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020027304A1 | Novel carotenoid-related derivatives, and salts, esters, or amides thereof | |
EP3753559A1 | Colitis improving agent | |
WO2019138995A1 | Dry eye remedy | |
WO2019111896A1 | Antipruritic agent | |
WO2019111897A1 | Dermatitis remedy | |
WO2019103139A1 | Optically active trans-astaxanthin derivative or salt thereof, and composition containing said compound | |
WO2019065674A1 | Osteoarthritis improving agent | |
AU2015262405A1 | Carotenoid derivative, pharmaceutically acceptable salt thereof, and pharmaceutically acceptable ester or amide thereof |